Insight Molecular Diagnostics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $518 | $2,138 | $1,486 | $115 |
Gross Profit | 350 | 1,325 | 975 | 50 |
EBITDA | -9,842 | -6,151 | -32,918 | -13,122 |
EBIT | -10,401 | -6,642 | -33,481 | -13,462 |
Net Income | -9,742 | -6,671 | -33,511 | -13,493 |
Net Change In Cash | 518 | 2,138 | 1,486 | 115 |
Free Cash Flow | -6,279 | -6,165 | -5,568 | -5,336 |
Cash | 24,287 | 31,029 | 8,636 | 3,363 |
Basic Shares | 320 | 256 | 13,071 | 13,714 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,881 | $1,503 | $958 | $2,198 |
Gross Profit | 740 | 501 | 78 | 188 |
EBITDA | -59,015 | -23,123 | -13,315 | -48,457 |
EBIT | -60,579 | -24,803 | -18,535 | -52,662 |
Net Income | -60,663 | -27,781 | -72,902 | -64,097 |
Net Change In Cash | 1,881 | 1,503 | 958 | 2,198 |
Free Cash Flow | -21,229 | -23,606 | -49,908 | -38,188 |
Cash | 8,636 | 9,432 | 19,993 | 35,605 |
Basic Shares | 13,071 | 7,651 | 5,540 | 4,446 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.30 |
2025-03-31 | -$0.22 |
2024-12-31 | -$1.93 |
2024-09-30 | -$0.98 |
